Jules A. Maltz - May 12, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: Director, 10%+ Owner
Signature: /s/ Soleil Boughton, Attorney-in-Fact
Stock symbol: HIMS
Transactions as of: May 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/16/2022, 08:58 PM
Previous filing: Mar 17, 2022
Next filing: Jun 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Other	+9.21K	+48.46%	28.2K	May 12, 2022	Direct	F1
holding	HIMS	Class A Common Stock				54K	May 12, 2022	Held by Institutional Venture Partners XV Executive Fund, L.P.	F2
holding	HIMS	Class A Common Stock				10.1M	May 12, 2022	Held by Institutional Venture Partners XV, L.P.	F2
holding	HIMS	Class A Common Stock				10.2M	May 12, 2022	Held by Institutional Venture Partners XVI, L.P.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b).
F2	Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

Content

Represents a pro-rata in-kind distribution of shares of Class A common stock, and not a purchase or sale, without consideration, which is therefore an exempt, non-matchable acquisition pursuant to Section 16(b).

Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.